Abstract: Subjects who are potentially impacted by a medical condition are identified. An experimental group includes subjects having a positive indication for a specific criterion related to the medical condition in their medical profiles. A control groups includes subjects having a negative indication for the specific criterion. An artificial intelligence system is trained using the specific criterion and secondary characteristics of the subjects of the experimental and control groups to construct a classifier for the medical condition. The classifier is used to extract a target group of subjects from a population of subjects. A medical profile of each subject of the target group is marked as potentially affected by the medical condition. A system includes the artificial intelligence system and a database for storing the medical profiles. Deep learning or machine learning may be used to analyze medical images such as retinal images.
Type:
Grant
Filed:
March 16, 2020
Date of Patent:
April 29, 2025
Assignee:
OPTINA DIAGNOSTICS, INC.
Inventors:
Jean Philippe Sylvestre, David Lapointe, Claudia Chevrefils
Abstract: The present disclosure relates to a method and a system for detecting an anomaly within a biological tissue. A first image of the biological tissue is obtained, the first image containing light at a first wavelength. A second image of the biological tissue is obtained, the second image containing light at a second wavelength. A texture analysis of the biological tissue is performed using spatial information of the first and second images. The texture analysis is resolved over the first and second wavelengths.
Type:
Grant
Filed:
October 19, 2017
Date of Patent:
March 30, 2021
Assignee:
OPTINA DIAGNOSTICS, INC.
Inventors:
Jean Philippe Sylvestre, David Lapointe, Claudia Chevrefils, Reza Jafari